PDS Biotech is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapies based on the Versamune® platform, a T-cell activating technology, designed to harness the power of the body's immune system in the fight against cancer and infectious disease.
Location: United States, New Jersey
Employees: 11-50
Total raised: $36.2M
Founded date: 2005
Investors 1
| Date | Name | Website |
| - | New Leaf V... | nlvpartner... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 24.08.2022 | - | $35M | - |
| 19.04.2022 | - | $1.2M | - |
Mentions in press and media 25
| Date | Title | Description | Source |
| 13.03.2024 | PDS Biotech Announces Publication of Preclinical Research an... | - | globenewsw... |
| 24.04.2023 | PDS Biotech Receives $1.4 Million After Selling Its Net Oper... | - | globenewsw... |
| 24.08.2022 | PDS Biotech Completes $35 Million Financing Agreement Led By... | Initial tranche of $25 million provides funding in preparation for registrational trial for lead can... | globenewsw... |
| 19.04.2022 | PDS Biotech Receives $1.2 Million After Selling Its Net Oper... | FLORHAM PARK, N.J., April 19, 2022 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB),... | globenewsw... |
| 02.02.2022 | PDS Biotech Announces Preliminary Efficacy Achievement in VE... | FLORHAM PARK, N.J., Feb. 02, 2022 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), ... | marketscre... |
| 02.02.2022 | PDS Biotechnology : Biotech Announces Preliminary Efficacy A... | PDS Biotech Announces Preliminary Efficacy Achievement in VERSATILE-002 Phase 2 Trial of PDS0101 in ... | marketscre... |
| 06.12.2021 | NetScientific : PDS Phase 2 Clinical Trial Update | NetScientific plc ("NetScientific", the "Group" or the "Company") PDS ... | marketscre... |
| 01.11.2021 | PDS to License Novel Proteins for Flu Vaccine | NetScientific plc ("NetScientific", the "Group" or the "Company") PDS ... | marketscre... |
| 06.10.2021 | PDS Biotechnology : Biotech Enrolls First Stage of Checkpoin... | PDS Biotech Enrolls First Stage of Checkpoint Inhibitor Naïve Patient Arm of Phase 2 Clinical Trial ... | marketscre... |
| 05.10.2021 | NetScientific : PDS Phase 2 Clinical Trial Update | NetScientific plc ("NetScientific", the "Group" or the "Company") PDS ... | marketscre... |
Show more